Balanced nutrition not only supports weight loss but also enhances overall health
Frozen GLP-1 medications should not be used
Selection between oral options for GLP-1 receptor agonists could ultimately be guided by prioritization of glycemic control, weight reduction and proven cardiovascular disease risk reduction, balanced against individual differences in tolerability (including sensitivity to gastrointestinal symptoms), administration convenience and other patient-specific factors, the researchers wrote.
Food and Drug Administration (FDA) approved a groundbreaking oral GLP-1 weight-loss medication the Wegovy pill from Novo Nordisk marking the first time a glucagon-like peptide-1 (GLP-1) receptor agonist for weight management can be taken as a daily tablet rather than by injection
Future research should prioritize clinically relevant biomarkers of oocyte aging and adopt interdisciplinary approaches combining molecular biology, environmental toxicology, metabolomics, and bioinformatics
A clinical study shows that when taken in moderation, berries have favorable effects on platelet count and HDL (also called good cholesterol) because of being rich in polyphenols that boost platelets
